BIB vs. CNCR ETF Comparison
Comparison of ProShares Ultra Nasdaq Biotechnology (BIB) to Loncar Cancer Immunotherapy ETF (CNCR)
BIB
ProShares Ultra Nasdaq Biotechnology
BIB Description
The investment seeks daily investment results that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index®. The fund invests in securities and derivatives that ProShare Advisors believes, in combination, should have similar daily return characteristics as two times (2x) the daily return of the index. The index is a modified capitalization weighted index that includes securities of NASDAQ listed companies that are classified as either biotechnology or pharmaceutical according to the Industry Classification Benchmark ("ICB") which also meet other eligibility criteria determined by NASDAQ. The fund is non-diversified.
Grade (RS Rating)
Last Trade
$61.67
Average Daily Volume
10,954
196
CNCR
Loncar Cancer Immunotherapy ETF
CNCR Description
ETF Series Solutions - Loncar Cancer Immunotherapy ETF is an exchange traded fund launched by ETF Series Solutions. The fund is co-managed by Exchange Traded Concepts, LLC and Vident Investment Advisory, LLC. It invests in public equity markets of the United States. The fund invests in stocks of companies operating in the pharmaceutical or biotechnology sectors, including those companies identified as having a high strategic focus on the development of drugs that harness the body's own immune system to fight cancer. It invests in stocks of companies across all market capitalizations. The fund seeks to replicate the performance of the Loncar Cancer Immunotherapy Index, by investing in stocks of companies as per their weightings in the index. ETF Series Solutions - Loncar Cancer Immunotherapy ETF is domiciled in the United States.Grade (RS Rating)
Last Trade
$14.74
Average Daily Volume
3,771
67
Performance
Period | BIB | CNCR |
---|---|---|
30 Days | -2.45% | 0.07% |
60 Days | -8.24% | -2.25% |
90 Days | -2.79% | 3.58% |
12 Months | 41.85% | 45.65% |
43 Overlapping Holdings
Symbol | Grade | Weight in BIB | Weight in CNCR | Overlap | |
---|---|---|---|---|---|
ACLX | B | 0.33% | 1.55% | 0.33% | |
ALLO | D | 0.04% | 1.35% | 0.04% | |
ARVN | C | 0.13% | 1.42% | 0.13% | |
AUTL | D | 0.06% | 1.51% | 0.06% | |
BCYC | D | 0.07% | 1.37% | 0.07% | |
BMEA | D | 0.03% | 1.91% | 0.03% | |
BNTX | B | 0.78% | 1.21% | 0.78% | |
BPMC | C | 0.38% | 1.32% | 0.38% | |
CGEM | F | 0.07% | 1.24% | 0.07% | |
CRBU | D | 0.01% | 1.28% | 0.01% | |
DAWN | A | 0.1% | 1.42% | 0.1% | |
ELVN | B | 0.1% | 1.75% | 0.1% | |
ERAS | C | 0.05% | 1.23% | 0.05% | |
EXEL | A | 0.57% | 1.39% | 0.57% | |
GERN | C | 0.17% | 1.26% | 0.17% | |
GMAB | F | 0.07% | 1.15% | 0.07% | |
HCM | C | 0.05% | 1.74% | 0.05% | |
IDYA | F | 0.18% | 1.08% | 0.18% | |
IMCR | F | 0.09% | 1.31% | 0.09% | |
IOVA | B | 0.23% | 1.35% | 0.23% | |
ITOS | F | 0.02% | 0.99% | 0.02% | |
JANX | A | 0.2% | 1.4% | 0.2% | |
KURA | F | 0.1% | 1.1% | 0.1% | |
KYMR | C | 0.23% | 1.36% | 0.23% | |
LEGN | F | 0.26% | 1.16% | 0.26% | |
LYEL | F | 0.02% | 1.25% | 0.02% | |
MGNX | C | 0.02% | 1.55% | 0.02% | |
MRUS | C | 0.26% | 1.41% | 0.26% | |
NRIX | B | 0.12% | 1.31% | 0.12% | |
NUVL | D | 0.4% | 1.13% | 0.4% | |
PGEN | F | 0.02% | 1.27% | 0.02% | |
RAPT | D | 0.0% | 1.23% | 0.0% | |
REGN | F | 4.63% | 1.1% | 1.1% | |
REPL | B | 0.06% | 1.55% | 0.06% | |
RLAY | F | 0.06% | 1.05% | 0.06% | |
RVMD | A | 0.57% | 1.47% | 0.57% | |
RXRX | F | 0.13% | 1.28% | 0.13% | |
SMMT | C | 1.01% | 0.92% | 0.92% | |
SNDX | F | 0.12% | 1.37% | 0.12% | |
SWTX | D | 0.15% | 1.09% | 0.15% | |
XNCR | A | 0.09% | 1.35% | 0.09% | |
YMAB | A | 0.05% | 1.54% | 0.05% | |
ZNTL | D | 0.02% | 1.22% | 0.02% |
BIB Overweight 153 Positions Relative to CNCR
Symbol | Grade | Weight | |
---|---|---|---|
GILD | A | 6.64% | |
VRTX | D | 5.62% | |
AMGN | C | 5.58% | |
AZN | F | 3.16% | |
ALNY | C | 2.7% | |
BIIB | F | 1.92% | |
ILMN | A | 1.61% | |
MRNA | F | 1.45% | |
ARGX | A | 1.27% | |
UTHR | A | 1.12% | |
SNY | D | 1.09% | |
VTRS | B | 0.98% | |
BMRN | F | 0.96% | |
PCVX | C | 0.9% | |
INCY | A | 0.9% | |
SRPT | D | 0.9% | |
RPRX | D | 0.88% | |
INSM | D | 0.88% | |
NBIX | C | 0.84% | |
MEDP | F | 0.73% | |
BGNE | C | 0.68% | |
ROIV | D | 0.62% | |
ITCI | A | 0.57% | |
ASND | F | 0.54% | |
JAZZ | D | 0.48% | |
HALO | B | 0.45% | |
CYTK | F | 0.44% | |
IONS | F | 0.41% | |
RNA | C | 0.38% | |
KRYS | C | 0.36% | |
RARE | D | 0.36% | |
CRNX | B | 0.34% | |
BBIO | D | 0.33% | |
MDGL | A | 0.32% | |
ALKS | F | 0.32% | |
IMVT | F | 0.32% | |
AXSM | C | 0.31% | |
CRSP | C | 0.29% | |
ADMA | B | 0.27% | |
DNLI | C | 0.27% | |
FOLD | B | 0.25% | |
APLS | F | 0.24% | |
XENE | C | 0.23% | |
PTCT | B | 0.23% | |
EWTX | B | 0.23% | |
RYTM | D | 0.22% | |
DYN | F | 0.22% | |
PTGX | B | 0.2% | |
ARWR | F | 0.18% | |
GH | D | 0.18% | |
VRNA | A | 0.18% | |
VCYT | A | 0.18% | |
AGIO | B | 0.18% | |
SRRK | B | 0.17% | |
TWST | F | 0.17% | |
ACAD | F | 0.17% | |
AMPH | A | 0.17% | |
VERA | A | 0.16% | |
KROS | A | 0.16% | |
VCEL | D | 0.15% | |
HRMY | D | 0.14% | |
MYGN | F | 0.14% | |
AKRO | A | 0.14% | |
LGND | A | 0.14% | |
MNKD | A | 0.13% | |
NVCR | F | 0.13% | |
BEAM | F | 0.13% | |
WVE | B | 0.13% | |
SUPN | B | 0.13% | |
MIRM | B | 0.13% | |
HROW | C | 0.13% | |
NTLA | F | 0.12% | |
ZLAB | B | 0.12% | |
BCRX | A | 0.12% | |
OCUL | B | 0.12% | |
TARS | A | 0.11% | |
SPRY | B | 0.11% | |
FTRE | F | 0.11% | |
RCKT | F | 0.11% | |
NVAX | F | 0.11% | |
IRON | D | 0.1% | |
ARDX | D | 0.1% | |
TVTX | B | 0.1% | |
DVAX | A | 0.1% | |
INVA | C | 0.09% | |
ANIP | F | 0.09% | |
COGT | B | 0.09% | |
GRFS | B | 0.08% | |
CNTA | A | 0.08% | |
COLL | F | 0.08% | |
PHAT | B | 0.08% | |
PETQ | A | 0.07% | |
ANAB | F | 0.07% | |
ARQT | D | 0.07% | |
EOLS | A | 0.07% | |
VIR | B | 0.07% | |
AUPH | A | 0.07% | |
MRVI | F | 0.07% | |
PCRX | C | 0.06% | |
ABCL | C | 0.06% | |
ETNB | D | 0.06% | |
PLRX | A | 0.06% | |
SANA | F | 0.06% | |
PRTA | F | 0.06% | |
CSTL | A | 0.06% | |
IRWD | F | 0.05% | |
LXRX | D | 0.05% | |
ADPT | A | 0.05% | |
OLMA | F | 0.05% | |
MLYS | B | 0.05% | |
HUMA | D | 0.05% | |
ABUS | D | 0.05% | |
PRME | C | 0.04% | |
URGN | F | 0.04% | |
ARCT | F | 0.04% | |
KALV | D | 0.04% | |
EYPT | C | 0.04% | |
THRD | A | 0.04% | |
SVRA | D | 0.04% | |
RVNC | C | 0.04% | |
ORIC | D | 0.04% | |
GLPG | F | 0.04% | |
CVAC | F | 0.04% | |
VYGR | C | 0.03% | |
TSHA | F | 0.03% | |
TBPH | C | 0.03% | |
FDMT | F | 0.03% | |
ALEC | D | 0.03% | |
OABI | D | 0.03% | |
MGTX | B | 0.03% | |
AVXL | A | 0.03% | |
PACB | C | 0.03% | |
SIGA | D | 0.03% | |
RGNX | F | 0.03% | |
TERN | D | 0.03% | |
PAHC | B | 0.03% | |
SAGE | F | 0.03% | |
XERS | A | 0.03% | |
VERV | C | 0.03% | |
AMRN | F | 0.02% | |
EDIT | F | 0.02% | |
VNDA | D | 0.02% | |
ACIU | F | 0.02% | |
QURE | B | 0.02% | |
ALXO | F | 0.01% | |
OVID | D | 0.01% | |
CHRS | F | 0.01% | |
ACRS | B | 0.01% | |
BLUE | F | 0.01% | |
VTYX | F | 0.01% | |
CABA | F | 0.01% | |
ATAI | F | 0.01% | |
FULC | F | 0.01% |
BIB Underweight 24 Positions Relative to CNCR
Symbol | Grade | Weight | |
---|---|---|---|
TYRA | F | -1.89% | |
AURA | B | -1.54% | |
KPTI | C | -1.5% | |
BMY | A | -1.43% | |
TSVT | D | -1.42% | |
MRSN | D | -1.41% | |
RPTX | C | -1.39% | |
RCUS | F | -1.38% | |
IGMS | B | -1.37% | |
GNLX | C | -1.32% | |
ACRV | B | -1.32% | |
ACET | F | -1.3% | |
STRO | D | -1.28% | |
SDGR | F | -1.23% | |
MRK | F | -1.22% | |
IPHA | D | -1.18% | |
GLUE | A | -1.17% | |
FHTX | C | -1.11% | |
FATE | F | -1.03% | |
IMRX | D | -1.02% | |
NUVB | F | -1.02% | |
IMTX | F | -0.99% | |
VOR | D | -0.94% | |
PRLD | F | -0.85% |
BIB: Top Represented Industries & Keywords
CNCR: Top Represented Industries & Keywords